Today's rapidly expanding drug development pipeline demands efficient and accurate quantitation of diverse drug candidates and their metabolites in biological matrices to provide critical pharmacokinetics insights supporting safe and efficacious studies. The rise of new drug modalities is challenging bioanalysis laboratories, requiring versatile and easy-to-adopt solutions that do not compromise on quantitative performance.
With Waters advanced UPLC-MS/MS technologies and performance-enabling chemistry and consumables, scientists can develop bespoke, highly sensitive, and robust analytical workflows for assessing pharmacokinetic profiles across diverse modalities. Bolstered by efficiency driving software for GLP and non-GLP environments, Waters solutions address today’s bioanalytical challenges across all stages of drug development.
